Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
4.21%
↑ 103% above average
Average (21q)
-134.58%
Historical baseline
Range
High:95.82%
Low:-2595.04%
Volatility
-1999.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 4.21% |
| Q2 2025 | -27.94% |
| Q1 2025 | 54.57% |
| Q4 2024 | -5.77% |
| Q3 2024 | -62.33% |
| Q2 2024 | 18.03% |
| Q1 2024 | 42.00% |
| Q4 2023 | -13.64% |
| Q3 2023 | 3.20% |
| Q2 2023 | 9.09% |
| Q1 2023 | 26.67% |
| Q4 2022 | -36.36% |
| Q3 2022 | -10.78% |
| Q2 2022 | -23.82% |
| Q1 2022 | -74.35% |
| Q4 2021 | 30.83% |
| Q3 2021 | 95.82% |
| Q2 2021 | -318.42% |
| Q1 2021 | -2595.04% |
| Q4 2020 | -28.18% |
| Q3 2020 | -48.65% |
| Q2 2020 | 0.00% |